What to Do About Neuropathic Pain?

2009-09-23T01:59:00.000-07:00

There has been a wealth of research into what causes pain. It is a symptom or warning of an underlying medical problem. Researchers can describe in detail how the sensation is transmitted from its source to the brain so we become aware of the problem and can take action to treat it. Unfortunately, despite our better understanding of what it is, actually relieving the pain remains a challenge. If we are dealing with a non-fatal physical injury, we can set the broken bones, stitch up the wounds and wait for the body to repair itself. During this time, the pain management choices for doctors focus on the various side effects of the medications, the interactions between medications, etc. If the pain becomes more acute due to a terminal condition, the issues of addiction and, to some extent, adverse side effects are less relevant. The humanitarian need is to make a person as comfortable as possible during the final period of life. But long-term neuropathic pain represents a completely different set of challenges.

Neuropathic pain is not properly understood and, consequently, not routinely diagnosed. It is caused by a lesion or dysfunction to the peripheral or central nervous system, i.e. the nervous system itself is damaged. The cause may be a physical injury or a disease may affect the way it works. Consequently, the pain may be caused by the damage to the nervous system itself or the system may be sending out general distress symptoms or, in some cases, false pain messages. Physical injuries to the nervous system are very difficult to treat because nerve tissue does not easily regenerate. In other cases, researchers do not properly understand why an apparently undamaged system may malfunction. Because the system that transmits and controls pain sensations may be damaged or not working properly, people often react to treatment in a wide variety of unpredictable ways. For the same reason, many prove more vulnerable than usual to adverse side effects. But the consequences of not providing effective pain relief can be serious. People who experience pain over a longer period of time are more likely to become depressed and may find it difficult to remain in paid work.

One of the main difficulties in treating neuropathic pain is that the usual opioid analgesics do not work well. Consequently, it can take longer for the medication to reach a stable and effective level in the blood stream. During the slow build up of the drug, people can become discouraged and either want to switch to another drug thought better or discontinue use of the immediate drug. In clinical trials of the opioids, more than a quarter of participants withdrew because of the physical and psychological side effects. This is unfortunate because it usually takes between four and six weeks for doctors to be able to assess the effectiveness of the chosen opioid.

But Ultram is an atypical opioid and its ability to relieve pain of all kinds makes it one of the first-response medications for the treatment of neuropathic pain. Doctors must, of course, take care to avoid adverse interactions with other medications, particularly the two classes of antidepressants: the Selective Serotonin Reuptake Inhibitors (SSRIs) and Monoamine Oxidase Inhibitors (MOIs). The other most common problem is that anyone with a history of seizures or who is being treated with medications that lower the seizure threshold may be at an increased risk of seizures if they are taking Ultram. However, ultram is generally preferred in cases of neuropathic pain because there are fewer problems of dependence so long as people use the medication as prescribed. In other words, the balance of advantages against disadvantages usually supports the use of ultram for the treatment of neuropathic pain.

Controlling Back Pain

2009-09-23T01:50:00.000-07:00

Back pain is particularly common and one of the most often cited reasons for a visit to the doctor. Unfortunately, the causes can be difficult to identify and even more difficult to treat. The pain can be a symptom of a simple muscular strain, or it may indicate a more serious underlying problem of injury to the spine or a disease. The primary reason for consulting the doctor is that the pain can significantly limit mobility.

Until your back is injured, you do not realise how often you twist and bend. Even sitting down, you are in motion, automatically changing position to maintain circulation, avoid stiffness in the joints, and so on. But when back pain strikes, it does not matter what you are doing. You can be sitting quietly doing nothing or driving, attempting to walk or doing some housework. Even lying down can be painful. The temptation is not to move. But the longer you stand or sit without moving, the stiffer you become. That is why you often see people with back pain bent over when they stand up. They have realized that straightening up is going to bring back the pain.

Ultram has consistently been found an effective treatment for lower back pain. Because it slows the transmission of pain signals within the central nervous systems, you will find you can sit for longer, drive or ride in a car without suffering additional pain and look after and play with your children. In short, ultram helps you lead a more normal life again. How to treat arthritis Arthritis is a group of conditions that affect the joints and it most commonly affects people aged more than 55 years. The damage may be due to a general degeneration in the joints or from some accident or injury that does not quickly heal. One of the first-responses used to be the non-steroidal anti-inflammatory drugs (NSAIDs), but there are some worrying side effects including the risks of stomach and small bowel ulcers, kidney and liver damage and, if used over time, a slight risk of strokes and heart attacks. This creates real problems for chronic conditions like osteoarthritis and explains why ultram has now overtaken the NSAIDs as the first-response medication for long-term pain relief.

Ultram relieves mild to severe pain by acting on the central nervous system to slow down the transmission of pain signals. It has none of the side effects associated with NSAIDs and is not addictive. In 2007, a meta research study into the safety and effectiveness of Ultram in the treatment of osteoarthritis analyzed the data from eleven clinical trials involving more than 2,000 participants. It concluded that, as against the placebo, there were real reductions in pain and a general improvement in the quality of life. But, because arthritis usually affects older people, lower doses must be used. There are also problems of adverse interactions if people are also taking selective serotonin reuptake inhibitors and other antidepressants. Always ask your doctor for advice before taking any new prescription medication.